More than 60% of patients with GATA6 mutations have pancreas defects that can lead to NDM, T2D, and/or pancreas agenesis, a condition in which the patient does not develop a pancreas or has a substantially smaller pancreas. Here, GATA6 is linked to type 2 diabetes mellitus.